We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
Cap. Flow
+$1.69B
Cap. Flow %
9.02%
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$140M
2
MSFT icon
Microsoft
MSFT
+$124M
3
AAPL icon
Apple
AAPL
+$117M
4
CARR icon
Carrier Global
CARR
+$94.7M
5
OTIS icon
Otis Worldwide
OTIS
+$88.7M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$47.8M
2
ABT icon
Abbott
ABT
+$25.1M
3
CL icon
Colgate-Palmolive
CL
+$24.3M
4
HRL icon
Hormel Foods
HRL
+$23.2M
5
WMT icon
Walmart Inc
WMT
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Consumer Discretionary 13.41%
3 Industrials 11.79%
4 Financials 10.2%
5 Healthcare 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNF icon
851
Fidelity National Financial
FNF
$13.9B
$632K ﹤0.01%
21,424
+3,278
+18% +$90.2K
RINF icon
852
ProShares Inflation Expectations ETF
RINF
$18.5M
$632K ﹤0.01%
+25,712
New +$619K
IOVA icon
853
Iovance Biotherapeutics
IOVA
$2.23B
$631K ﹤0.01%
22,976
-1,232
-5% -$40.5K
WING icon
854
Wingstop
WING
$3.68B
$629K ﹤0.01%
+4,524
New +$527K
WMGI
855
DELISTED
Wright Medical Group Inc
WMGI
$629K ﹤0.01%
21,172
+10,133
+92% +$296K
CBPO
856
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$628K ﹤0.01%
6,150
+850
+16% +$91K
MGEE icon
857
MGE Energy Inc
MGEE
$3.11B
$626K ﹤0.01%
9,711
+3,238
+50% +$211K
LGND icon
858
Ligand Pharmaceuticals
LGND
$6.02B
$625K ﹤0.01%
8,951
+2,444
+38% +$155K
FHI icon
859
Federated Hermes
FHI
$4.4B
$624K ﹤0.01%
26,313
+11,064
+73% +$245K
NUVA
860
DELISTED
NuVasive, Inc.
NUVA
$624K ﹤0.01%
11,203
+5,315
+90% +$307K
RDN icon
861
Radian Group
RDN
$5.14B
$619K ﹤0.01%
39,912
+15,355
+63% +$227K
DNLI icon
862
Denali Therapeutics
DNLI
$3.67B
$615K ﹤0.01%
25,424
+9,145
+56% +$215K
GBT
863
DELISTED
Global Blood Therapeutics, Inc.
GBT
$615K ﹤0.01%
9,736
-1,946
-17% -$133K
TCF
864
DELISTED
TCF Financial Corporation Common Stock
TCF
$615K ﹤0.01%
20,899
+5,538
+36% +$153K
CNO icon
865
CNO Financial Group
CNO
$4.97B
$612K ﹤0.01%
39,285
+15,425
+65% +$213K
KMPR icon
866
Kemper
KMPR
$1.7B
$612K ﹤0.01%
8,435
+2,154
+34% +$144K
CACI icon
867
CACI
CACI
$10.8B
$611K ﹤0.01%
2,815
+948
+51% +$227K
CADE
868
DELISTED
Cadence Bank
CADE
$610K ﹤0.01%
26,805
+11,430
+74% +$242K
IPGP icon
869
IPG Photonics
IPGP
$3.89B
$610K ﹤0.01%
3,805
+650
+21% +$92.6K
RS icon
870
Reliance Steel & Aluminium
RS
$20.8B
$603K ﹤0.01%
6,349
+1,689
+36% +$154K
HRC
871
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$603K ﹤0.01%
5,490
+1,814
+49% +$190K
MOS icon
872
The Mosaic Company
MOS
$7.09B
$600K ﹤0.01%
47,949
+4,180
+10% +$50.1K
VMW
873
DELISTED
VMware, Inc
VMW
$599K ﹤0.01%
3,869
+908
+31% +$125K
KOD icon
874
Kodiak Sciences
KOD
$2.59B
$597K ﹤0.01%
11,028
+3,295
+43% +$186K
STAG icon
875
STAG Industrial
STAG
$7.86B
$597K ﹤0.01%
+20,375
New +$536K

Similar funds

ProShare Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.

  • ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
  • ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
  • ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
  • ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
  • ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
  • ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
  • ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.

Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.